[Caihua News] Stone four Pharmaceutical Group (02005.HK) announced that it will repurchase 924000 shares on January 25, 2022 at a repurchase price of HK $3.59 to HK $3.65 per share, involving an investment of 3.36 million yuan.
The cumulative number of securities repurchased so far this year (since the passing of the ordinary resolution) is 31.836 million shares, accounting for 1.052% of the number of shares issued at the time of the passing of the ordinary resolution.
The cumulative number of securities repurchased so far this year (since the passing of the ordinary resolution) is 31.836 million shares, accounting for 1.052% of the number of shares issued at the time of the passing of the ordinary resolution.